trial

Cognitive Training for Patients With Schizophrenia

NCTId NCT01521026
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 69 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2009-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
69 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2003-09
Primary completion
2009-08
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive training

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Alliance for Research on Schizophrenia and DepressionCollaborator

Investigators

1
Elizabeth W. Twamley, PhDPrincipal Investigator

Sites

1 total
San Diego, United States

Facts & assertions

4 sourced
Enrollment
69
Phase
NA
Primary Completion Date
2009-08
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive training
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Alliance for Research on Schizophrenia and Depression
company
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
Elizabeth W. Twamley, PhD
person